Does Aurinia Pharmaceuticals Inc (AUPH) Have What it Takes to be in Your Portfolio Tuesday?

Aurinia Pharmaceuticals Inc (AUPH) is around the top of the Biotechnology industry according to InvestorsObserver. AUPH received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Aurinia Pharmaceuticals Inc also achieved a score of 83 in the Biotechnology industry, putting it above 83 percent of Biotechnology stocks. Biotechnology is ranked 49 out of the 148 industries.

AUPH has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on AUPH!

See Full AUPH Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aurinia Pharmaceuticals Inc Stock Today?

Aurinia Pharmaceuticals Inc (AUPH) stock is up 1.41% while the S&P 500 is lower by -0.33% as of 11:45 AM on Tuesday, Nov 21. AUPH is up $0.13 from the previous closing price of $9.24 on volume of 3,680,792 shares. Over the past year the S&P 500 has gained 14.75% while AUPH is up 101.94%. AUPH lost -$0.54 per share the over the last 12 months. Click Here to get the full Stock Report for Aurinia Pharmaceuticals Inc stock.